Founded in 2005, ORTHOCON is a startup therapeutic device company that develops, manufactures, markets and sells innovative surgical products that stop the bleeding from and deliver drugs to bone. In 2010, ORTHOCON launched its first FDA-cleared product, the HEMASORB Absorbable Bone Hemostat Matrix. ORTHOCON believes its products have the potential to provide significant benefits to millions of patients each year.